Essange Reagents

Activities: Analysis

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Analysis

Sanquin to exhibit at PDA Europe

Meet the team to discover its new test kit and test-service based on cryopreserved PBMCs and IL-6 read outs
Analysis

Sanquin exhibits at Pharmalab Congress

Sanquin is the first company worldwide to introduce a test kit and test-service based on cryopreserved PBMCs and IL-6 read outs
Research & Development

Sanquin contributes to European research against MS

Sanquin researchers Dr Anja ten Brinke and Professor Marieke van Ham take part in a European consortium that aims to find a cure for multiple sclerosis

Reliable and reproducible Monocyte Activation Test

Sanquin Reagents has developed a reliable and reproducible Monocyte Activation Test (MAT), which can replace rabbit testing for measuring endotoxin and non-endotoxin pyrogens

Masterclass on Biologics — towards personalised medicine

27 October | Workshop | Amsterdam, Netherlands

New worldwide exclusive license and collaboration for immuno-oncology therapeutic leads

Synthon Biopharmaceuticals BV, an international biopharmaceutical company that is focused on developing new molecular entities for treating cancer and autoimmune diseases, has announced a new license and collaboration agreement for the development of novel immuno-oncology antibodies with Sanquin Blood Supply Foundation (‘Sanquin’), Amsterdam
Subscribe now